Flosequinan
From Self-sufficiency
| File:Flosequinan.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
7-fluoro-3-methanesulfinyl-1-methyl-1,4-dihydroquinolin-4-one | |
| Identifiers | |
| CAS Number | 76568-02-0 |
| ATC code | C01DB01 (WHO) |
| PubChem | CID 4474062 |
| Chemical data | |
| Formula | C11H10FNO2S |
| Molar mass | 239.267 g/mol[[Script error: No such module "String".]] |
Flosequinan is a quinolone vasodilator. It has direct relaxing effects on peripheral arteries and veins. It is administered orally in cases of congestive heart failure in patients who are not responsive to digitalis or ACE inhibitors. It was sold under the trade name Manoplax.
It was withdrawn from the US market in October 1993 due to an increased risk of hospitalization or death.[1]
References
Cite error: Invalid <references> tag;
parameter "group" is allowed only.
<references />, or <references group="..." />
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- ↑ "Heart drug withdrawn - Boots Pharmaceuticals' Manoplax". Retrieved 2008-12-01.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Withdrawn drugs
- Vasodilators
- Quinolines
- Sulfoxides
- Ketones
- Organofluorides
- Cardiovascular system drug stubs
